Details
| Stereochemistry | ABSOLUTE |
| Molecular Formula | C30H38N2O2 |
| Molecular Weight | 458.6349 |
| Optical Activity | UNSPECIFIED |
| Defined Stereocenters | 1 / 1 |
| E/Z Centers | 0 |
| Charge | 0 |
SHOW SMILES / InChI
SMILES
[H][C@]1(CCC2=CC(O)=CC=C2C1)C3=C(C=C(OC)C=C3)N(CC)CC4=CC=C(CCNCC)C=C4
InChI
InChIKey=SIFNOOUKXBRGGB-AREMUKBSSA-N
InChI=1S/C30H38N2O2/c1-4-31-17-16-22-6-8-23(9-7-22)21-32(5-2)30-20-28(34-3)14-15-29(30)26-11-10-25-19-27(33)13-12-24(25)18-26/h6-9,12-15,19-20,26,31,33H,4-5,10-11,16-18,21H2,1-3H3/t26-/m1/s1
Approval Year
| Name | Type | Language | ||
|---|---|---|---|---|
|
Official Name | English | ||
|
Code | English | ||
|
Code | English | ||
|
Code | English | ||
|
Systematic Name | English | ||
|
Common Name | English | ||
|
Systematic Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Systematic Name | English |
| Classification Tree | Code System | Code | ||
|---|---|---|---|---|
|
NCI_THESAURUS |
C1821
Created by
admin on Sat Dec 16 09:42:51 UTC 2023 , Edited by admin on Sat Dec 16 09:42:51 UTC 2023
|
| Code System | Code | Type | Description | ||
|---|---|---|---|---|---|
|
GH-120
Created by
admin on Sat Dec 16 09:42:51 UTC 2023 , Edited by admin on Sat Dec 16 09:42:51 UTC 2023
|
PRIMARY | |||
|
RAD-1901
Created by
admin on Sat Dec 16 09:42:51 UTC 2023 , Edited by admin on Sat Dec 16 09:42:51 UTC 2023
|
PRIMARY | Study to Evaluate the Safety and Efficacy of RAD1901 in Postmenopausal Women With Moderate to Severe Vasomotor Symptoms | ||
|
C120211
Created by
admin on Sat Dec 16 09:42:51 UTC 2023 , Edited by admin on Sat Dec 16 09:42:51 UTC 2023
|
PRIMARY | |||
|
RAD-1901
Created by
admin on Sat Dec 16 09:42:51 UTC 2023 , Edited by admin on Sat Dec 16 09:42:51 UTC 2023
|
PRIMARY | Description: RAD1901 is an orally available, selective estrogen receptor degrader (SERD) and selective estrogen receptor modulator (SERM), with potential antineoplastic and estrogen-like activities. Upon oral administration of higher doses of RAD1901, this agent acts as a SERD, which binds to the estrogen receptor (ER) and induces a conformational change that results in the degradation of the receptor. This may inhibit the growth and survival of ER-expressing cancer cells. At lower doses of this agent, RAD1901 acts as a SERM and has estrogen-like effects in certain tissues, which can both reduce hot flashes and protect against bone loss. In addition, RAD1901 is able to cross the blood-brain barrier (BBB). (last updated: 5/19/2016).Synonym: RAD1901, RAD-1901, RAD 1901, RAD1901 HCl salt. | ||
|
CHEMBL3545015
Created by
admin on Sat Dec 16 09:42:51 UTC 2023 , Edited by admin on Sat Dec 16 09:42:51 UTC 2023
|
PRIMARY | |||
|
100000170507
Created by
admin on Sat Dec 16 09:42:51 UTC 2023 , Edited by admin on Sat Dec 16 09:42:51 UTC 2023
|
PRIMARY | |||
|
SUB184531
Created by
admin on Sat Dec 16 09:42:51 UTC 2023 , Edited by admin on Sat Dec 16 09:42:51 UTC 2023
|
PRIMARY | |||
|
722533-56-4
Created by
admin on Sat Dec 16 09:42:51 UTC 2023 , Edited by admin on Sat Dec 16 09:42:51 UTC 2023
|
PRIMARY | |||
|
DTXSID901045846
Created by
admin on Sat Dec 16 09:42:51 UTC 2023 , Edited by admin on Sat Dec 16 09:42:51 UTC 2023
|
PRIMARY | |||
|
FM6A2627A8
Created by
admin on Sat Dec 16 09:42:51 UTC 2023 , Edited by admin on Sat Dec 16 09:42:51 UTC 2023
|
PRIMARY | |||
|
DB06374
Created by
admin on Sat Dec 16 09:42:51 UTC 2023 , Edited by admin on Sat Dec 16 09:42:51 UTC 2023
|
PRIMARY | |||
|
FM6A2627A8
Created by
admin on Sat Dec 16 09:42:51 UTC 2023 , Edited by admin on Sat Dec 16 09:42:51 UTC 2023
|
PRIMARY | |||
|
23642301
Created by
admin on Sat Dec 16 09:42:51 UTC 2023 , Edited by admin on Sat Dec 16 09:42:51 UTC 2023
|
PRIMARY | |||
|
Elacestrant
Created by
admin on Sat Dec 16 09:42:51 UTC 2023 , Edited by admin on Sat Dec 16 09:42:51 UTC 2023
|
PRIMARY | |||
|
10247
Created by
admin on Sat Dec 16 09:42:51 UTC 2023 , Edited by admin on Sat Dec 16 09:42:51 UTC 2023
|
PRIMARY |
ACTIVE MOIETY
SALT/SOLVATE (PARENT)
